Archive: 08/08/2022
Study discloses clinical-relevant intertumoral heterogeneity of NSCLCs driven by MET exon 14 skipping
A study presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna disclosed the clinical-relevant intertumoral heterogeneity of non-small cell lung cancer (NSCLC) driven by MET exon 14 skipping.
Aug 8, 2022